Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genolution Inc. (225220:KRX), powered by AI.
Genolution Inc. is currently trading at ₩1,810. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genolution Inc. on Alpha Lenz.
Genolution Inc.'s P/E ratio is -4.8.
“Genolution Inc. trades at a P/E of -4.8 (undervalued) with modest ROE of -8.1%.”
Ask for details →Genolution Inc. is a biotechnology company that specializes in genetic research and development, primarily focused on enhancing precision medicine. The company's core function is to apply cutting-edge genetic engineering techniques to develop diagnostics, therapeutics, and vaccines. Genolution Inc. plays a pivotal role in the healthcare and pharmaceuticals sectors by providing innovative solutions that address complex genetic disorders. Their work is crucial for advancing personalized medicine, enabling tailored treatments based on an individual's genetic makeup. By engaging in collaborations with research institutions and other biotech firms, Genolution Inc. contributes to the broader scientific community and the ongoing evolution of healthcare innovation. With a commitment to improving patient outcomes and fostering scientific advancement, Genolution Inc. remains a key player in the global biotech market.
“Genolution Inc. trades at a P/E of -4.8 (undervalued) with modest ROE of -8.1%.”
Ask for details →